Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients

BACKGROUND: Parkinson’s disease (PD) affects an estimated 7 to 10 million people worldwide, and only symptomatic treatments are presently available to relieve the consequences of brain dopaminergic neurons loss. Neuronal degeneration in PD is the consequence of neuroinflammation in turn influenced b...

Descripción completa

Detalles Bibliográficos
Autores principales: Kustrimovic, Natasa, Comi, Cristoforo, Magistrelli, Luca, Rasini, Emanuela, Legnaro, Massimiliano, Bombelli, Raffaella, Aleksic, Iva, Blandini, Fabio, Minafra, Brigida, Riboldazzi, Giulio, Sturchio, Andrea, Mauri, Marco, Bono, Giorgio, Marino, Franca, Cosentino, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044047/
https://www.ncbi.nlm.nih.gov/pubmed/30001736
http://dx.doi.org/10.1186/s12974-018-1248-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044047/
https://www.ncbi.nlm.nih.gov/pubmed/30001736
http://dx.doi.org/10.1186/s12974-018-1248-8

Ejemplares similares